Results 201 to 210 of about 4,813,932 (329)

Chromosome aberrations and DNA damage in a human gingival keratinocyte cell line induced by tobacco-specific N-nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone(NNK).

, 1997
Satoshi Maezawa, Minoru Uchida, Takeki Tsutsui   +2 more
openalex   +2 more sources

The first scientific experiment using Global e-VLBI observations: a multiwavelength campaign on the gamma-ray Narrow-Line Seyfert 1 PMN J0948+0022 [PDF]

, 2011
M. Giroletti, Z. Paragi, Hayley Bignall, Akihiro Doi, L. Foschini, K. É. Gabányi, J. Blanchard, F. Colomer, Xiaoyu Hong, M. Kadler, Motoki Kino, Huib Jan van Langevelde, Hiroshi Nagai, Chris Phillips, Mamoru Sekido, Arpad Szomoru, A. K. Tzioumis   +16 more
openalex   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Antagonistic regulation of LINE-1/Alu elements and their repressor APOBEC3B in cellular senescence. [PDF]

Mob DNA
Munot D, Lu Y, Haußmann I, Najjar G, Baur C, Singh M, Günes C, Sauter D, Arora A.   +8 more
europepmc   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Systemic LINE-1 RNA in Plasma Extracellular Vesicles Drives Neuroinflammation and Cognitive Dysfunction via cGAS-STING Pathway in Aging. [PDF]

Aging Cell
Yu S, Cheng Q, Yu Q, Cui Z, Chen H, Wu S, Jin Y, Wang Y, Li M, Lu Z.   +9 more
europepmc   +1 more source

Effects of indole-3-butyric acid and 1-naphthaleneacetic acid on in vitro rooting and the substrate mixing ratio on growth during the nursery stage of Mai vang (Ochna integerrima) HD01 line

Kevin Nguyen, Dung X. Pham, V.H. Giang Phan, Tri M. Bui, Lídia Hau   +4 more
openalex   +2 more sources

OS13-1 Numerical Simulation of Molding-defects Formation using BEM and Line Dynamics during RTM(Meso-scale damage mechanics,OS13 Micro- and meso-mechanics of composites,MICRO AND NANO MECHANICS)

, 2015
Yasuhiro Shimada, Ryosuke Matsuzaki, Atsushi Takahashi   +2 more
openalex   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source